OPTISCHES DOSISDEKODIERVERFAHREN

European patent · EP3248637 · In force

Register entry

Publication number
EP3248637
Application number
EP17170336
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Jan 13, 2014
Published
Nov 29, 2017
Granted
Nov 4, 2020
Protection ends at the latest
Jan 12, 2034
Next annual fee due
Jan 31, 2027
IPC classes
A61M 5/315 (2006.01)
H04L 9/32 (2006.01)
A61M 5/20 (2006.01)
A61M 5/24 (2006.01)
G01D 5/12 (2006.01)
G01D 5/26 (2006.01)
G01D 5/347 (2006.01)
Priority
EP 13151368 15.01.2013
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Feb 1, 2026

    Change

    Published in Swissreg on 01.02.2026

  2. Feb 1, 2025

    Change

    Published in Swissreg on 01.02.2025

  3. Feb 1, 2024

    Change

    Published in Swissreg on 01.02.2024

  4. Feb 1, 2023

    Change

    Published in Swissreg on 01.02.2023

  5. Nov 4, 2020

    Granted

    Published in Swissreg on 04.11.2020

Parties

Holder

Sanofi-Aventis Deutschland GmbH

Brüningstraße 50, 65929 Frankfurt, DE

Inventor

MORRIS, Anthony Paul

Coventry, West Midlands CV7 7FY, GB

GILMORE, Stephen Francis

Bristol, BS1 6XD, GB

DRAPER, Paul Richard

Evesham, Worcestershire WR11 3FE, GB

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.